Business
HistoSonics Expands Insurance Coverage for Non-Invasive Liver Tumor Treatment to 45.4 Million Elevance Health Members
MINNEAPOLIS, October 22, 2025--HistoSonics Expands Insurance Coverage for Non-Invasive Liver Tumor Treatment to 45.4 Million Elevance Health Members
About this update from Elevance Health, Inc.
[{"type":"image","alt":"HistoSonics Non-Invasive Edison Histotripsy System. Image credit: HistoSonics","displaySize":"","headline":null,"caption":"HistoSonics Non-Invasive Edison Histotripsy System. Image credit: HistoSonics","credit":null,"className":"","disableSlideshowImg":false,"size":{"original":{"width":480,"height":270,"url":"https://media.zenfs.com/en/business-wire.com/8cfa6cdb49ad4849a84792a8dc99a9c9"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/zunsc_Kbr_aDU1dCJUj7gg--/YXBwaWQ9aGlnaGxhbmRlcjt3PTk2MDtoPTU0MDtjZj13ZWJw/https://media.zenfs.com/en/business-wire.com/8cfa6cdb49ad4849a84792a8dc99a9c9","width":480,"height":270}},"lazy":false},{"type":"image","alt":"","displaySize":"","headline":null,"caption":"","credit":null,"className":"","disableSlideshowImg":false,"size":{"original":{"width":480,"height":480,"url":"https://media.zenfs.com/en/business-wire.com/99b164c1f40a798b6666141642dbac17"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/OhIsnCzndiLdSbptnURgkQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTk2MDtoPTk2MDtjZj13ZWJw/https://media.zenfs.com/en/business-wire.com/99b164c1f40a798b6666141642dbac17","width":480,"height":480}}},{"type":"list","items":[{"val":[{"type":"text","content":"Coverage effective across Elevance Health’s commercial, Medicare, and Medicaid plans in 14 states","length":97,"tagName":"p","attribs":{}}]},{"val":[{"type":"text","content":"Decision informed by growing clinical evidence, with additional real-world and long-term safety and efficacy data now being collected across global centers","length":155,"tagName":"p","attribs":{}}]}],"tagName":"ul","bulletedList":true,"length":252,"olType":false},{"type":"text","content":"MINNEAPOLIS, October 22, 2025--(BUSINESS WIRE)--HistoSonics, the developer of the Edison® Histotripsy System and novel histotripsy therapy platform, today announced that Elevance Health (formerly Anthem, Inc.) has issued a positive medical policy for the use of histotripsy in the treatment of liver tumors.","length":307,"tagName":"p"},{"type":"text","content":"The policy, effective October 21, 2025, expands insurance coverage across Elevance Health’s commercial, Medicare, and Medicaid plans in 14 states, including California, Colorado, Connecticut, Georgia, Indiana, Kentucky, Maine, Missouri, Nevada, New Hampshire, New York, Ohio, Virginia, and Wisconsin, broadening access to HistoSonics’ incisionless, non-the...